5,6-dihydro-5-azacytidine has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asmeron, Y; Blayney, D; Carr, BI; Doroshow, JH; Goldberg, D; Leong, L; Rahbar, S | 1 |
| Carr, DT; Dhingra, HM; Holoye, PY; Lee, JS; Murphy, WK; Umsawasdi, T | 1 |
2 other study(ies) available for 5,6-dihydro-5-azacytidine and Cancer of Lung
| Article | Year |
|---|---|
Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma.
Topics: Adult; Antibodies, Antinuclear; Azacitidine; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Fetal Hemoglobin; Gene Expression Regulation; Globins; Heart Diseases; Humans; Lung Neoplasms; Neoplasm Proteins; Pain; Transcriptional Activation | 1987 |
Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1987 |